HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M W Fanger Selected Research

MDX-H210 antibody

2/2001Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu.
2/2001Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M W Fanger Research Topics

Disease

2Neoplasms (Cancer)
02/2001 - 02/2001
1Autoimmune Diseases (Autoimmune Disease)
12/2001
1Adenocarcinoma
02/2001
1Prostatic Neoplasms (Prostate Cancer)
01/2001
1Carcinoma (Carcinomatosis)
11/2000
1Glioblastoma (Glioblastoma Multiforme)
11/2000
1Glioma (Gliomas)
11/2000
1Infertility (Sterility)
11/2000

Drug/Important Bio-Agent (IBA)

2MDX-H210 antibodyIBA
02/2001 - 02/2001
1VaccinesIBA
12/2001
1Immunoglobulin G (IgG)IBA
02/2001
1Fc Receptors (Fc Receptor)IBA
02/2001
1Superoxides (Superoxide)IBA
02/2001
1CytokinesIBA
02/2001
1EnzymesIBA
02/2001
1Interferon-gamma (Interferon, gamma)IBA
02/2001
1LigandsIBA
01/2001
1IgG Receptors (Fc gamma RI)IBA
01/2001
1Biological ProductsIBA
01/2001
1ErbB Receptors (EGF Receptor)IBA
11/2000
1EndotoxinsIBA
11/2000
1PKH 26IBA
11/2000

Therapy/Procedure

1Therapeutics
12/2001